Literature DB >> 19200814

Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants.

Yoko Shoji1, Christine E Farrance, Hong Bi, Moneim Shamloul, Brian Green, Slobodanka Manceva, Amy Rhee, Natalia Ugulava, Gourgopal Roy, Konstantin Musiychuk, Jessica A Chichester, Vadim Mett, Vidadi Yusibov.   

Abstract

Highly pathogenic avian influenza (HPAI) viruses of the H5N1 subtype have been identified as a potential pandemic threat by the World Health Organization (WHO). Since 1997, these viruses have been spreading from Asia to Europe and Africa with increasing genetic and antigenic diversities. Vaccination is the preferred strategy for the prevention and control of influenza infections and the availability of a system for the rapid engineering and production of vaccines is required in the event of an influenza pandemic. In this study, we engineered and produced recombinant hemagglutinin (HA) from A/Bar-headed Goose/Qinghai/1A/05 (clade 2.2) and A/Anhui/1/2005 (clade 2.3) in Nicotiana benthamiana plants. Immunization of mice with these plant-derived HA antigens elicited serum hemagglutination inhibition (HI) and virus neutralization (VN) antibodies. These results suggest the utility of our plant-expression system for recombinant influenza vaccine production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200814     DOI: 10.1016/j.vaccine.2009.01.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.

Authors:  Teen-Lee Pua; Xiao Ying Chan; Hwei-San Loh; Abdul Rahman Omar; Vidadi Yusibov; Konstantin Musiychuk; Alexandra C Hall; Megan V Coffin; Yoko Shoji; Jessica A Chichester; Hong Bi; Stephen J Streatfield
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

2.  Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection.

Authors:  Donata Kalthoff; Anatoli Giritch; Katharina Geisler; Ulrike Bettmann; Victor Klimyuk; Hans-Robert Hehnen; Yuri Gleba; Martin Beer
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

3.  Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.

Authors:  Stephen Tottey; Yoko Shoji; R Mark Jones; Jessica A Chichester; Brian J Green; Konstantin Musiychuk; Huaxin Si; Slobodanka D Manceva; Amy Rhee; Moneim Shamloul; Joey Norikane; Rosane C Guimarães; Elena Caride; Andrea N M R Silva; Marisol Simões; Patricia C C Neves; Renato Marchevsky; Marcos S Freire; Stephen J Streatfield; Vidadi Yusibov
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

4.  A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum.

Authors:  Christine E Farrance; Amy Rhee; R Mark Jones; Konstantin Musiychuk; Moneim Shamloul; Satish Sharma; Vadim Mett; Jessica A Chichester; Stephen J Streatfield; Will Roeffen; Marga van de Vegte-Bolmer; Robert W Sauerwein; Takafumi Tsuboi; Olga V Muratova; Yimin Wu; Vidadi Yusibov
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

5.  Membrane-based inverse transition cycling: an improved means for purifying plant-derived recombinant protein-elastin-like polypeptide fusions.

Authors:  Hoang Trong Phan; Udo Conrad
Journal:  Int J Mol Sci       Date:  2011-04-29       Impact factor: 5.923

6.  A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.

Authors:  R Mark Jones; Jessica A Chichester; Slobodanka Manceva; Sandra K Gibbs; Konstantin Musiychuk; Moneim Shamloul; Joey Norikane; Stephen J Streatfield; Marga van de Vegte-Bolmer; Will Roeffen; Robert W Sauerwein; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  High accumulation in tobacco seeds of hemagglutinin antigen from avian (H5N1) influenza.

Authors:  Yanaysi Ceballo; Kenia Tiel; Alina López; Gleysin Cabrera; Marlene Pérez; Osmany Ramos; Yamilka Rosabal; Carlos Montero; Rima Menassa; Ann Depicker; Abel Hernández
Journal:  Transgenic Res       Date:  2017-10-06       Impact factor: 2.788

8.  Plant-produced human recombinant erythropoietic growth factors support erythroid differentiation in vitro.

Authors:  Konstantin Musiychuk; Rajarajeswari Sivalenka; Jennifer Jaje; Hong Bi; Rosemary Flores; Brenden Shaw; R Mark Jones; Tatiana Golovina; Jacob Schnipper; Luipa Khandker; Ruiqiang Sun; Chang Li; Lin Kang; Vanessa Voskinarian-Berse; Xiaokui Zhang; Stephen Streatfield; John Hambor; Stewart Abbot; Vidadi Yusibov
Journal:  Stem Cells Dev       Date:  2013-05-14       Impact factor: 3.272

9.  The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

Authors:  Åsne Jul-Larsen; Abdullah S Madhun; Karl A Brokstad; Emanuele Montomoli; Vidadi Yusibov; Rebecca J Cox
Journal:  Hum Vaccin Immunother       Date:  2012-05-01       Impact factor: 3.452

10.  An interspecific Nicotiana hybrid as a useful and cost-effective platform for production of animal vaccines.

Authors:  Huai-Yian Ling; Aaron M Edwards; Michael P Gantier; Kathleen D Deboer; Alan D Neale; John D Hamill; Amanda M Walmsley
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.